|
Volumn 87, Issue 5 PART 2, 1996, Pages 814-817
|
Treatment of essential thrombocythemia during pregnancy with interferon-α
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALPHA INTERFERON;
ALPHA2A INTERFERON;
ALPHA2B INTERFERON;
ANTINEOPLASTIC AGENT;
HYDROXYUREA;
ADULT;
ARTICLE;
BONE MARROW SUPPRESSION;
CASE REPORT;
CONGENITAL MALFORMATION;
DRUG EFFICACY;
FEMALE;
HUMAN;
LEUKEMIA;
MYELOPROLIFERATIVE DISORDER;
ORAL DRUG ADMINISTRATION;
PREGNANCY;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SUBCUTANEOUS DRUG ADMINISTRATION;
TERATOGENICITY;
THROMBOCYTE COUNT;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
TRANSITIONAL BLINDNESS;
ADULT;
ASPIRIN;
FEMALE;
HUMANS;
INFANT, NEWBORN;
INTERFERON-ALPHA;
MALE;
PLATELET AGGREGATION INHIBITORS;
PREGNANCY;
PREGNANCY COMPLICATIONS, HEMATOLOGIC;
PREGNANCY OUTCOME;
THROMBOCYTHEMIA, HEMORRHAGIC;
|
EID: 0029912538
PISSN: 00297844
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (58)
|
References (15)
|